Clarification sought from Aurobindo Pharma

05 Mar 2018 Evaluate

The Exchange has sought clarification from Aurobindo Pharma on March 05, 2018 with reference to news flashed on www.moneycontrol.com dated March 05, 2018 quoting ‘US FDA observations - Aurobindo Unit 4 inspected by US FDA from February 12-20 and issues 9 observations.’

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1167.05 -5.60 (-0.48%)
13-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.80
Dr. Reddys Lab 1190.35
Cipla 1447.60
Zydus Lifesciences 900.25
Lupin 2176.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×